Global Blood Therapeutics (GBT) Reports In-Line Q3 Loss
Tweet
Share
E-mail
Get Alerts GBT Hot Sheet
Price: $68.49 --0%
Financial Fact:
Earnings per share - diluted: 0.12
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Earnings per share - diluted: 0.12
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q3 EPS of ($0.58), in-line with the analyst estimate of ($0.58).
Cash and cash equivalents totaled $217.8 million at September 30, 2016, compared with $148.5 million at December 31, 2015.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- ResMed (RMD) Tops Q3 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
